Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2023-02-17 00:00:00 ET · period of report 2023-02-15 · accession 0001104659-23-023305 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-17 | 2023-02-15 | ANIP | Mutz Christopher | HEAD OF RARE DISEASE | F - Tax | $45.04 | -1,292 | 39.6K | -3% | -$58.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-15 | F | D | 1,292 | $45.04 | 39,562 | D | — | — |